Navigation Links
TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
Date:3/2/2009

ee, President and CEO of TissueGene. "And I believe our success thus far can be attributed primarily to the strategic alliance between TissueGene, Kolon and KLS. By bridging our domestic and international resources, this business model has not only enabled for rapid preclinical and clinical development, but has allowed for innovative cost control mechanisms and significant long-term growth opportunities."

About TissueGene, Inc.

TissueGene, Inc. is a Maryland-based biopharmaceutical company with a strong global vision focused on developing a proprietary and innovative suite of regenerative orthopedic therapeutic products. Founded in 1999, the Company's primary pipeline is focused on the treatment and regeneration of damaged cartilage, bones, disc and nerves. The Company's core technology employs a form of cell-mediated gene therapy to deliver well-known therapeutic proteins to localized areas of damaged tissue. The sustained expression of such proteins, along with the cellular matrix it is delivered in, initiates rapid and permanent repair of injured tissue without the need for invasive surgical procedures. The Company has successfully demonstrated the growth of cartilage, bone, nerve and tendons in animals. For more information, please visit www.TissueGene.com .

About Kolon Life Science, Inc.

Kolon Life Science, Inc. (KLS), a subsidiary company of Kolon, is a leading biochemical company in Korea focused on research and discovery in the life sciences. In 2006, Kolon established KLS by merging TissueGene Asia Co., Ltd with their existing active pharmaceutical ingredients (APIs) and specialty chemicals business. For more information, please visit www.kolonls.co.kr .


'/>"/>
SOURCE TissueGene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
2. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
3. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
4. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
5. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
6. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
7. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
8. Kensey Nash Announces IDE Submission for Cartilage Repair Device
9. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
10. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
11. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, ... York , recently was awarded the George Roentsch ... Vernak received the award in Houston ... The scholarship is awarded annually to an independent pharmacist ... nature of George Roentsch , a well-known pharmacist ...
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms ... subtle or unnoticed, but new technology, coupled with ... and leading to earlier detection of eye diseases, ... 29 million Americans. If left untreated, these diseases ... blindness. Recently, optometric researchers have ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... Delcath Systems, Inc. (Nasdaq: DCTH ), a developmental stage ... that it will open the NASDAQ stock market on Friday, ... Times Square in New York City will be broadcast ... NASDAQ webcam. The live ceremony, including President and Chief Executive Officer ...
... Inc. (Nasdaq: MYL ) today announced that it increased the ... pricing.  Mylan priced $550 million aggregate principal amount of ... and $700 million aggregate principal amount of 7.875% Senior ... to use approximately $1.0 billion of the net proceeds ...
Cached Medicine Technology:Delcath's Eamonn Hobbs to Ring NASDAQ Opening Bell 2Mylan Announces Upsizing and Pricing of Senior Notes 2Mylan Announces Upsizing and Pricing of Senior Notes 3
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... men may lead to increased blood pressure, according to a ... rise in blood pressure for young adult women or for ... women drank lightly or moderately, their risk of high blood ... finding parallels studies in older adult men and women," said ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter TUESDAY, ... diagnosed with Ebola while working for NBC News in ... the special isolation unit at Nebraska Medical Center in Omaha, where ... said Tuesday. A blood test confirmed by the U.S. Centers ... head home to Providence, R.I., NBC News reported Tuesday ...
(Date:10/20/2014)... MA (PRWEB) October 20, 2014 ... sponsoring a booth at the American Foundation for Suicide ... 25th. The AFSP is a not-for-profit organization that hosts ... Net proceeds from these events are used to help ... but education and personal relationships as well. , ...
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... posture support/brace, designed to combat rounded shoulders syndrome, which can cause ... working at a computer, more people are suffering the effects of ... can be worn everyday. , ... (PRWEB) August 1, ...
... ... ... ), a leading pharmaceutical, biotechnology and medical device research and,development ... has appointed Mr. Steven M. Hutchins as,Vice President of Business Development., (Logo: ...
... Bipartisan Leadership in,Helping to Avert $770 Million FY ... Seniors, WASHINGTON, July 31 The American ... Nursing Home Care applaud,today,s decision by the Bush ... of key Republican and Democratic congressional,leaders with spearheading ...
... Unit in Leeds receives Lilly,s 2008 Global ... ... Inc. (NYSE:,CVD), a leading provider of drug development services, today announced ... Lilly and Company., Covance,s clinical research unit based in Leeds, ...
... GXDX ), a specialized laboratory services provider, today reported,revenues ... and $50.1 million,for the first half of 2008, as ... the respective periods in 2007. Stated revenue for the,first ... changes in,accounting estimates relating to prior periods., "Our ...
... 31 Handa Pharmaceuticals, LLC,("Handa"), a specialty ... that its Abbreviated New Drug Application ("ANDA") ... of,AstraZeneca,s SEROQUEL(R) XR, has been accepted for ... ("FDA"). Based upon available information, Handa,believes that ...
Cached Medicine News:Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 2Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 3Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 4Health News:WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development 2Health News:AHCA-Alliance Praise Bush Administration for Reversing Planned Medicare Cuts, Protecting Seniors 2Health News:Covance Recognized for Outstanding Customer Service by Eli Lilly and Company 2Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 2Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 3Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 4Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 5Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 6Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 7Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 8Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 9Health News:Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZeneca's SEROQUEL(R) XR 2
Anesthesia Associates Nerve Stimulator Model AA 1050...
... A range of easy to use instruments ... nerve locator, peripheral nerve stimulator, and muscle ... pole, plastic hub, and pencil point needles., ... inexpensive, practical and easy to use stimulator, ...
... nerve stimulator from B. Braun Medical. It ... stimulator functionality for over 10 years. , ... a unique, under-the-glove hand held remote current ... It allows the anesthesia provider operating solo ...
... the original MS-III design the ... enhanced keypad and ... MiniStim® MS-IV peripheral nerve stimulator ... monitoring in operating room, post ...
Medicine Products: